Vivani Medical

About Vivani Medical

Vivani Medical is focused on developing miniaturized, long-term biopharmaceutical implants to address medication non-adherence and tolerability in chronic disease treatment. Their mission is to free patients from adherence challenges, minimizing the burden and maximizing the benefits of clinical treatments through innovative implant technology.

Products & Services

NanoPortal™ Implant Technology:A novel implant technology designed to deliver steady doses of medication over extended periods, addressing challenges associated with fluctuating drug delivery.

NPM-115 (GLP-1 for Obesity):A miniature, six-month subdermal high-dose exenatide implant for chronic weight management in obese or overweight patients, insertable during a quick outpatient procedure. Currently under study in the LIBERATE-1 Phase 1 clinical trial.

NPM-119 (GLP-1 for Type 2 Diabetes):A miniature, six-month subdermal exenatide implant for treating type 2 diabetes, designed to provide steady medication doses for up to six months.

NPM-139 (Semaglutide Implant):A novel semaglutide implant under rapid advancement for weight loss, supported by positive preclinical data and promising results from the LIBERATE-1 study.

OKV-119 for Dogs:A collaborative development with Okava targeting pre-diabetes and diabetes in dogs.

NPM-139 (semaglutide implant for weight management)

NPM-115 (exenatide implant)

NPM-133 (semaglutide implant for type 2 diabetes)

NanoPortal implant technology

Specialties

Biopharmaceutical Implants Chronic Disease Treatment Medication Adherence Solutions NanoPortal™ Technology GLP-1 Therapies for Obesity and Diabetes Miniature subdermal drug implants Ultra long-acting biopharmaceutical delivery Chronic disease treatment (obesity, diabetes)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 4500000 MR: - FA: approximately $4.5 million FAN: 4500000	D: 2026-01-27 FD: 2026-01-27	1 investors
2	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 4500000 MR: - FA: approximately $4.5 million FAN: 4500000	D: 2026-01-25 FD: 2026-01-25	1 investors
3	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 15700000 MR: - FA: approximately $15.7 million FAN: 15700000	D: 2025-10-28 FD: 2025-10-28	1 investors
4	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 15700000 MR: - FA: approximately $15.7 million FAN: 15700000	D: 2025-10-26 FD: 2025-10-26	1 investors
5	RT: Private Placement T: - FT: Private Placement	A: 8250000 MR: - FA: 8.25 million FAN: 8250000	D: 2025-03-27 FD: 2025-03-27	1 investors
6	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 15000000 MR: - FA: $15.0 million FAN: 15000000	D: 2024-03-01 FD: 2024-03-01	1 investors

Registered Direct Offering and Private Placement Latest

2026-01-27

$4.5M

1 investor (Pro only)

Registered Direct Offering and Private Placement 2026-01-25

$4.5M

Registered Direct Offering and Private Placement 2025-10-28

$15.7M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Adam Mendelsohn

Co-Founder & Chief Executive Officer

T

Truc Le

Chief Operations Officer

L

Lisa Porter

Chief Medical Officer

A

Anthony Baldor

Chief Financial Officer

D

Don Dwyer

Chief Business Officer

G

Gregg Williams

Director & Chairman of the Board

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Vivani Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised